Zerbe Robert L Md sold 2,000 shares of Vericel Corp at $57.88 for −$116k on Nov 9, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$115,760Shares × reported price
Shares traded
2,000Common Stock
Price per share
$57.88Reported price. Read footnotes for ranges.
% of reported position traded
5.72%This security and ownership context
Holdings after
32,995Direct
Trade date
Nov 9, 2026Sell
Filed
Nov 12, 2026, 7:43 PM ET4-day reporting delay
Accession
0001140361-26-043488Code S · Transaction 399973
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 34,995 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 9, 2026Option exercise2,000$0.00$0Trade 399974
Nov 9, 2026Option exercise2,000$13.05$26,100Trade 399972
3 transaction rows in this filing. Joint filers share the same rows.

VCEL price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
VCEL · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −30%1w ago −25%1d ago −4.9%
Returns since7d30d90d180d1y

Footnotes in full

F1: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026. F2: These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.